Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2873 Carcinoma, Non-Small-Cell Lung 2426 Breast Neoplasms 2067 Colorectal Neoplasms 1245 Neoplasm Metastasis 1231 Prostatic Neoplasms 1080 Melanoma 974 Multiple Myeloma 963 Ovarian Neoplasms 904 Recurrence 852 Leukemia, Myeloid, Acute 810 Lung Neoplasms 757 Pancreatic Neoplasms 752 Lymphoma, Non-Hodgkin 727 Lymphoma 660 Stomach Neoplasms 623 Carcinoma, Hepatocellular 566 Carcinoma, Renal Cell 546 Squamous Cell Carcinoma of Head and Neck 529 Leukemia, Lymphocytic, Chronic, B-Cell 493 Lymphoma, Follicular 468 Head and Neck Neoplasms 451 Glioblastoma 435 Advanced Solid Tumors 432 Small Cell Lung Carcinoma 411 Triple Negative Breast Neoplasms 409 Lymphoma, Large B-Cell, Diffuse 398 Leukemia 394 Uterine Cervical Neoplasms 369 Advanced Solid Tumor 351

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × Osteochondroma × Clear all

NCT03442985 2022-08-01

MO-Ped

Ipsen

Phase 2 Terminated

193 enrolled 20 charts

Exostoses, Multiple Hereditary, Osteochondroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡